Home ›
NPI 1861731523
NPI deactivated
1861731523
1861731523 was paid $1.46M by Medicaid between Jan 2018 and May 2021, across 39 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider info1861731523
33aNPI1861731523
33bProvider type—
28Total paid$1.46M
24GClaims37,372
24DCodes billed39
24AFirst – last monthJan 2018 – May 2021
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,456 | $711K | |
| 2019 | 9,593 | $332K | |
| 2020 | 8,407 | $307K | |
| 2021 | 2,916 | $106K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 3,027 | 2,925 | $396K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 2,308 | 2,233 | $217K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 9.6% | 911 | 906 | $139K |
| S4993 | Contraceptive pills for birth control | 7.7% | 934 | 929 | $112K |
| J3490 | Unclassified drugs | 7.6% | 4,044 | 3,128 | $110K |
| 87806 | 4.8% | 3,173 | 2,392 | $70K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.9% | 2,666 | 2,541 | $57K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.0% | 169 | 166 | $44K |
| 99201 | 2.8% | 392 | 391 | $41K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 2.3% | 41 | 41 | $33K |
| 99402 | 1.9% | 888 | 884 | $28K | |
| 58300 | 1.9% | 311 | 161 | $28K |
27 more codes
| 99401 | 1.7% | 1,281 | $24K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 321 | $22K |
| A4267 | Contraceptive supply, condom, male, each | 1.2% | 2,020 | $18K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 1.0% | 1,161 | $15K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | <1% | 28 | $11K |
| 83986 | <1% | 3,563 | $9K | |
| J7304 | Contraceptive supply, hormone containing patch, each | <1% | 12 | $9K |
| S5000 | Prescription drug, generic | <1% | 1,349 | $9K |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 12 | $8K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 2,542 | $7K |
| 99403 | <1% | 142 | $6K | |
| 11981 | <1% | 29 | $6K | |
| 81025 | <1% | 2,257 | $5K | |
| 99000 | <1% | 1,582 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 121 | $5K |
| 58301 | <1% | 176 | $5K | |
| Q3014 | Telehealth originating site facility fee | <1% | 210 | $4K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 14 | $4K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 532 | $2K |
| 99070 | <1% | 294 | $2K | |
| 11976 | <1% | 46 | $2K | |
| 81002 | <1% | 496 | $781.88 | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 200 | $589.69 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 17 | $369.75 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 16 | $339.78 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 58 | $334.17 |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 29 | $60.92 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.